Free Trial

SelectQuote Target of Unusually High Options Trading (NYSE:SLQT)

SelectQuote logo with Finance background
Remove Ads

SelectQuote, Inc. (NYSE:SLQT - Get Free Report) saw some unusual options trading activity on Friday. Traders purchased 4,430 call options on the company. This represents an increase of 128% compared to the typical daily volume of 1,943 call options.

Insider Activity

In other news, insider Sarah Taylor Anderson sold 50,000 shares of the stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $5.44, for a total transaction of $272,000.00. Following the completion of the transaction, the insider now directly owns 1,166 shares in the company, valued at $6,343.04. This represents a 97.72 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 11.40% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On SelectQuote

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in SLQT. Creative Planning raised its position in shares of SelectQuote by 6.6% in the third quarter. Creative Planning now owns 100,019 shares of the company's stock valued at $217,000 after purchasing an additional 6,150 shares during the period. KCM Investment Advisors LLC acquired a new stake in SelectQuote during the third quarter worth approximately $608,000. Connor Clark & Lunn Investment Management Ltd. lifted its position in SelectQuote by 17.1% during the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 623,548 shares of the company's stock worth $1,353,000 after acquiring an additional 91,071 shares during the last quarter. Intech Investment Management LLC bought a new stake in shares of SelectQuote during the third quarter worth approximately $123,000. Finally, Charles Schwab Investment Management Inc. grew its position in shares of SelectQuote by 4.7% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,181,663 shares of the company's stock valued at $2,564,000 after purchasing an additional 53,159 shares during the last quarter. 34.59% of the stock is owned by institutional investors.

Remove Ads

SelectQuote Stock Performance

NYSE:SLQT traded down $0.06 during mid-day trading on Friday, hitting $3.55. The stock had a trading volume of 1,744,455 shares, compared to its average volume of 1,259,601. SelectQuote has a twelve month low of $1.48 and a twelve month high of $6.86. The company has a debt-to-equity ratio of 2.10, a quick ratio of 6.36 and a current ratio of 6.36. The stock has a market cap of $610.25 million, a price-to-earnings ratio of -39.39 and a beta of 1.13. The company's 50 day simple moving average is $4.45 and its 200 day simple moving average is $3.30.

SelectQuote (NYSE:SLQT - Get Free Report) last released its quarterly earnings data on Monday, February 10th. The company reported $0.30 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.09 by $0.21. SelectQuote had a negative return on equity of 4.38% and a negative net margin of 0.95%. On average, equities research analysts forecast that SelectQuote will post -0.07 earnings per share for the current year.

Analyst Ratings Changes

SLQT has been the topic of several recent analyst reports. Noble Financial raised SelectQuote to a "strong-buy" rating in a research report on Wednesday, February 12th. Royal Bank of Canada restated a "sector perform" rating and set a $4.00 target price on shares of SelectQuote in a report on Friday, November 22nd.

View Our Latest Stock Analysis on SelectQuote

SelectQuote Company Profile

(Get Free Report)

SelectQuote, Inc operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related products, including prescription drugs, dental, vision, and hearing plans; life insurance products, such as term life, final expense, and other ancillary products, including critical illness, accidental death, and juvenile insurance; homeowners, auto, dwelling fire, and other ancillary insurance products; and non-commercial auto and home property, and casualty policies.

Featured Articles

Should You Invest $1,000 in SelectQuote Right Now?

Before you consider SelectQuote, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SelectQuote wasn't on the list.

While SelectQuote currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

3 AI Stocks to Watch After NVIDIA’s Dip

3 AI Stocks to Watch After NVIDIA’s Dip

NVIDIA may be down, but the AI boom isn’t slowing anytime soon! While investors react to short-term price swings, smart money is looking at three stocks that could benefit from NVIDIA’s continued domi

Related Videos

7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads